Literature DB >> 23277803

Successful treatment of extensive vitiligo with monobenzone.

Ole Martin Rordam1, Eric William Lenouvel, Martine Maalo.   

Abstract

Vitiligo is one of the most common dermatological disorders, appearing as one or more white macules or patches and affecting up to two percent of the population worldwide. The undesirable aesthetic properties of vitiligo, especially facial, may result in significant negative psychosocial effects, particularly a rate of depression twice that of the general population. While there is no cure, there are several treatment options, notably depigmentation in severe cases. Monobenzone is the most potent depigmenting agent. However, its use is limited due to the permanent and potent nature of the drug. This case presents an example of when timely and aggressive treatment with monobenzone is warranted, demonstrating excellent clinical response, which resulted in a significant increase in the quality of life in a patient with severe vitiligo.

Entities:  

Year:  2012        PMID: 23277803      PMCID: PMC3533321     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  12 in total

1.  Evaluation of monobenzone.

Authors:  S W BECKER; M C SPENCER
Journal:  JAMA       Date:  1962-04-28       Impact factor: 56.272

2.  Vitiligo: Emerging paradigms.

Authors:  Davinder Parsad
Journal:  Indian J Dermatol Venereol Leprol       Date:  2012 Jan-Feb       Impact factor: 2.545

Review 3.  Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up.

Authors:  Ali Alikhan; Lesley M Felsten; Meaghan Daly; Vesna Petronic-Rosic
Journal:  J Am Acad Dermatol       Date:  2011-09       Impact factor: 11.527

Review 4.  Vitiligo: a comprehensive overview Part II: treatment options and approach to treatment.

Authors:  Lesley M Felsten; Ali Alikhan; Vesna Petronic-Rosic
Journal:  J Am Acad Dermatol       Date:  2011-09       Impact factor: 11.527

5.  The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force.

Authors:  Alain Taïeb; Mauro Picardo
Journal:  Pigment Cell Res       Date:  2007-02

Review 6.  Depigmentation therapies for normal skin in vitiligo universalis.

Authors:  K M AlGhamdi; A Kumar
Journal:  J Eur Acad Dermatol Venereol       Date:  2010-11-04       Impact factor: 6.166

7.  Depigmentation therapies in vitiligo.

Authors:  Divya Gupta; Rashmi Kumari; Devinder Mohan Thappa
Journal:  Indian J Dermatol Venereol Leprol       Date:  2012 Jan-Feb       Impact factor: 2.545

8.  The burden of vitiligo: patient characteristics associated with quality of life.

Authors:  May W Linthorst Homan; Phyllis I Spuls; John de Korte; Jan D Bos; Mirjam A Sprangers; J P Wietze van der Veen
Journal:  J Am Acad Dermatol       Date:  2009-07-03       Impact factor: 11.527

9.  Combination of 4-hydroxyanisole and all-trans retinoic acid produces synergistic skin depigmentation in swine.

Authors:  X Nair; P Parab; L Suhr; K M Tramposch
Journal:  J Invest Dermatol       Date:  1993-08       Impact factor: 8.551

10.  Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature.

Authors:  D B Mosher; J A Parrish; T B Fitzpatrick
Journal:  Br J Dermatol       Date:  1977-12       Impact factor: 9.302

View more
  1 in total

1.  Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation.

Authors:  Jungang Chen; Lu Dai; Alana Goldstein; Haiwei Zhang; Wei Tang; J Craig Forrest; Steven R Post; Xulin Chen; Zhiqiang Qin
Journal:  PLoS Pathog       Date:  2019-12-02       Impact factor: 6.823

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.